Catalyst Wire Dossier Catalyst Wire Dossier

RSV-F protein particle vaccine

RSV fusion (F) protein particle vaccine · Novavax, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RSV-F protein particle vaccine, covering 2012-03-08 to 2012-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety Study of Respiratory Syncytial Virus (RSV)-Fusion (F) Protein Particle Vaccine [Phase 1]

See pricing